Nuveen Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.11M | Hold |
167,716
| – | – | ﹤0.01% | 2363 |
|
|
2024
Q3 | $3.1M | Hold |
167,716
| – | – | ﹤0.01% | 2218 |
|
|
2024
Q2 | $3.61M | Buy |
167,716
+7,680
| +5% | +$165K | ﹤0.01% | 2102 |
|
|
2024
Q1 | $4.31M | Sell |
160,036
-3,383
| -2% | -$91.1K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $4.9M | Buy |
163,419
+11,738
| +8% | +$352K | ﹤0.01% | 1987 |
|
|
2023
Q3 | $3.11M | Sell |
151,681
-2,764
| -2% | -$56.6K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $3.07M | Buy |
154,445
+1,222
| +0.8% | +$24.3K | ﹤0.01% | 2143 |
|
|
2023
Q1 | $2.62M | Sell |
153,223
-350,498
| -70% | -$6M | ﹤0.01% | 2227 |
|
|
2022
Q4 | $9.86M | Buy |
503,721
+271,332
| +117% | +$5.31M | ﹤0.01% | 1499 |
|
|
2022
Q3 | $3.71M | Sell |
232,389
-127,151
| -35% | -$2.03M | ﹤0.01% | 2066 |
|
|
2022
Q2 | $4.95M | Buy |
359,540
+73,491
| +26% | +$1.01M | ﹤0.01% | 1948 |
|
|
2022
Q1 | $4.33M | Buy |
286,049
+134,610
| +89% | +$2.04M | ﹤0.01% | 2140 |
|
|
2021
Q4 | $3.31M | Sell |
151,439
-18,139
| -11% | -$396K | ﹤0.01% | 2325 |
|
|
2021
Q3 | $5.07M | Sell |
169,578
-104,351
| -38% | -$3.12M | ﹤0.01% | 2201 |
|
|
2021
Q2 | $12.1M | Buy |
273,929
+58,375
| +27% | +$2.59M | ﹤0.01% | 1733 |
|
|
2021
Q1 | $9.56M | Buy |
215,554
+77,714
| +56% | +$3.45M | ﹤0.01% | 1827 |
|
|
2020
Q4 | $4.42M | Sell |
137,840
-143,124
| -51% | -$4.58M | ﹤0.01% | 2139 |
|
|
2020
Q3 | $6.42M | Sell |
280,964
-84,567
| -23% | -$1.93M | ﹤0.01% | 1790 |
|
|
2020
Q2 | $7.65M | Buy |
365,531
+66,754
| +22% | +$1.4M | ﹤0.01% | 1670 |
|
|
2020
Q1 | $4.17M | Buy |
298,777
+188,830
| +172% | +$2.63M | ﹤0.01% | 1817 |
|
|
2019
Q4 | $2.5M | Buy |
109,947
+6,129
| +6% | +$139K | ﹤0.01% | 2331 |
|
|
2019
Q3 | $1.21M | Sell |
103,818
-4,874
| -4% | -$56.8K | ﹤0.01% | 2616 |
|
|
2019
Q2 | $1.63M | Buy |
+108,692
| New | +$1.63M | ﹤0.01% | 2528 |
|